Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2025-12-24 @ 3:30 PM
NCT ID:
NCT05364892
Eligibility Criteria:
Inclusion Criteria:
* Major patients with no upper age limit.
* Patients assessed as part of the reference centre for rare autoimmune diseases at the CHRU in Brest.
* Patients for whom a diagnosis of ANCA-associated vasculitis is made by the physician in charge of the patient, according to the definitions of the Chapel-Hill Consensus Conference.
* Patient affiliated with Social Security
* Patient who has signed written informed consent
Exclusion Criteria:
* Minor
* Patients unable to consent.
* Patients refusing to participate in research
* Patient under legal protection (tutelage, curatorship)
* Pregnant or lactating women
* Hemoglobin (Hb) \< 7g/dL
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT05364892
Study Brief:
Protocol Section:
NCT05364892